Complement activation by myeloperoxidase products released from stimulated human polymorphonuclear leukocytes

Immunobiology

Volumn 195, Issue 3, 1996, Pages 334-346

  Vogt, Walther ^a  

^a MAX PLANCK INSTITUTE OF EXPERIMENTAL MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMINE DERIVATIVE; CHLORIDE; COMPLEMENT COMPONENT C5; COMPLEMENT MEMBRANE ATTACK COMPLEX; HYDROGEN PEROXIDE; HYPOCHLORITE; MYELOPEROXIDASE; TAURINE;

ARTICLE; COMPLEMENT ACTIVATION; HUMAN; HUMAN CELL; NEUTROPHIL; PRIORITY JOURNAL;

EID: 0029793161     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0171-2985(96)80050-7     Document Type: Article

References (54)

1. BABIOR, B. M. 1978. Oxygen-dependent microbial killing by phagocytes. N. Engl. J. Med. 298: 659.
2. MAKINO, R., T. TANAKA, T. IIZUKA, Y. ISHIMURA, and S. KANEGASAKI. 1986. Stoichiometric conversion of oxygen to superoxide anion during the respiratory burst in neutrophils. J. biol. Chem. 261: 11444.
3. WINTERBOURN, C. C. 1981. Hydroxyl radical production in body fluids. Roles of metal ions, ascorbate and superoxide. Biochem. J. 198: 125.
4. MCCORD, J. M., and E. D. DAY. 1978. Superoxide-dependent production of hydroxyl radicals catalyzed by iron-EDTA complex. FEBS Lett. 86: 139.
5. HARRISON, J. E., and J. SCHULTZ. 1976. Studies on the chlorinating activity of myeloperoxidase. J. biol. Chem. 251: 1371.
6. WEISS, S. J. 1989. Tissue destruction by neutrophils. New Engl. J. Med. 320: 365.
7. VOGT, W. 1995. Oxidation of methionyl residues in proteins: tools, targets, and reversal. Free Radic. Biol. & Med. 18: 93.
8. CHEVION, M. 1988. A site-specific mechanism for free radical induced biological damage: the essential role of redox-active transition metals. Free Radic. Biol. & Med. 5: 27.
9. HALLIWELL, B., and C. M. C. GUTTERIDGE. 1992. Biologically relevant metal-ion-dependent hydroxyl radical generation. An update. FEBS Lett. 307: 108
10. WEISS, S. J., M. B. LAMPERT, and S. T. TEST. 1983. Long-lived oxidants generated by human neutrophils. Characterization and bioactivity. Science 222: 625.
11. THOMAS, E. L., M. B. GRISHAM, and M. M. JEFFERSON. 1983. Myeloperoxidase-dependent effect of amines on functions of isolated neutrophils. J. clin. Invest. 72: 441.
12. TEST, S. T., M. B. LAMPERT, P. J. OSSANNA, J. G. THOENE, and S. J. Weiss. 1984. Generation of nitrogen-chlorine oxidants by human phagocytes. J. clin. Invest. 74: 1341.
13. GRISHAM, M. B., M. M. JEFFERSON, and E. L. THOMAS. 1984. Role of monochloramine in the oxidation of erythrocyte hemoglobin by stimulated neutrophils. J. biol. Chem. 259: 6757.
14. GRISHAM, M. B., M. M. JEFFERSON, D. F. MELTON, and E. L. THOMAS. 1984. Chlorination of endogenous amines by isolated neutrophils. J. biol. Chem. 259: 10404.
15. WEISS, S. J., R. KLEIN, A. SLIVKA, and M. WEI. 1982. Chlorination of taurine by human neutrophils. J. clin. Invest. 70: 598.
16. VOGT, W., B. DAMERAU, I. VON ZABERN, R. NOLTE, and D. BRUNAHL. 1989. Nonenzymic activation of the fifth component of human complement, by oxygen radicals. Some properties of the activation product, C5b-like C5. Mol. Immunol. 26: 1133.
17. VOGT, W., B. ZIMMERMANN, D. HESSE, and R. NOLTE. 1992. Activation of the fifth component of human complement, without cleavage, by methionine oxidizing agents. Mol. Immunol. 29: 251.
18. VOGT, W., and D. HESSE. 1994. Oxidants generated by the myeloperoxidase-halide system activate the fith component of human complement, C5. Immunobiol. 192: 1.
19. VOGT, W., and D. HESSE. 1992. Activation of the fifth component of human complement by oxygen-derived free radicals, and by methionine oxidizing agents: a comparison. Immunobiol. 184: 384.
20. WARD, P. A., and J. H. HILL. 1970. C5 chemotactic fragments produced by an enzyme in lysosomal granules of neutrophils. J. Immunol. 104: 535.
21. WETSEL, R. A., and W. P. KOLB. 1983. Expression of C5a-like biological activities by the fifth component of human complement (C5) upon limited digestion with non-complement enzymes without release of polypeptide fragments. J. exp. Med. 157: 2029.
22. VENGE, P., and I. OLSSON. 1975. Cationic proteins of human granulomes. VI. Effects on the complement system and mediation of chemotactic activity. J. Immunol. 115: 1505.
23. MAYER, M. M. 1961. Complement and complement fixation. In: KABAT, E. A., and M. M. MAYER. Experimental Immunochemistry, 2nd ed., Charles C. Thomas, Springfield, Ill., 133 pp.
24. VOGT, W., R. NOLTE, and D. BRUNAHL. 1991. Binding of iron to the 5th component of human complement directs oxygen radical-mediated conversion to specific sites and causes non-enzymic activation. Complement Inflammation 8: 313.
25. HAMMER, C. H., G. H. WIRTZ, L. RENFER, H. D. GRESHAM, and B. F. TACK, 1981. Large scale isolation of functionally active components of the human complement system. J. biol. Chem. 256: 3995.
26. OPPERMANN, M., and O. GÖTZE. 1994. Plasma clearance of the human C5a anaphylatoxin by binding to leucocyte C5a receptors. Immunology 82: 516.
27. Worthington Enzyme Manual. 1988. ed. C. C. Worthington, Freehold, N. J., p. 255.
28. PILLEMER, L., and E. E. ECKER. 1941. Anticomplementary factor in fresh yeast. J. biol. Chem. 137: 139.
29. THOMAS, E. L., M. B. GRISHAM, and M. M. JEFFERSON. 1986. Preparation and characterization of chloramines. Meth. Enzymol. 132: 569.
30. THOMPSON, R. A., and P. J. LACHMANN. 1970. Reactive lysis: the complement mediated lysis of unsensitized cells. I. The characterization of the indicator factor and its identification as C7. J. exp. Med. 131: 629.
31. THOMAS, E. L., M. B. GRISHAM, D. F. MELTON, and M. M. JEFFERSON. 1985. Evidence for a role of taurine in the in vitro oxidative toxicity of neutrophils toward erythrocytes. J. biol. Chem. 260: 3321.
32. THOMAS, E. L. 1979. Myeloperoxidase, hydrogen peroxide, chloride antimicrobial system: nitrogen-chloride derivatives of bacterial compnents in bactericidal action against Escherichia coli. Infect. Immun. 23: 522.
33. THOMAS, E. L., M. M. JEFFERSON, and M. B. GRISHAM. 1982. Myeloperoxidase-catalyzed incorporation of amines into proteins: role of hypochlorous acid and dichloramines. Biochemistry 21: 6299.
34. DISCIPIO, R. G., C. A. SMITH, H. J. MÜLLER-EBERHARD, and T. E. HUGLI. 1983. The activation of human complement component C5 by a fluid phase C5 convertase. J. biol. Chem. 258: 10629.
35. KLEBANOFF, S. J. 1988. Phagocytic cells: products of oxygen metabolism. In: GALLIN, J. I., I. M. GOLDSTEIN, and R. SNYDERMAN. Inflammation: Basic principles and clinical correlates. Raven Press, Ltd., New York, 391 pp.
36. TILL, G. O., M. L. MORGANROTH, R. KUNKEL, and P. A. WARD. 1987. Activation of C5 by cobra venom factor is required in neutrophil-mediated lung injury in the rat. Am. J. Pathol. 129: 44.
37. SMITH, J. K., M. B. GRISHAM, D. N. GRANGER, and R. J. KORTHUIS. 1989. Free radical defense mechanisms and neutrophil infiltration in postischemic skeletal muscle. Am. J. Physiol. 256: H789.
38. FANTONE, J. C., and P. A. WARD. 1982. Role of oxygen-derived free radicals and metabolites in leukocyte-dependent inflammatory reactions. Am. J. Pathol. 107: 397.
39. LUCCHESI, B. R. 1993. Complement activation, neutrophils, and oxygen radicals in reperfusion injury. Stroke 24, Suppl. I: I-41.
40. SCHÄFER, H., D. MATHEY, F. HUGO, and S. BHAKDI. 1986. Deposition of the terminal C5b-9 complex in infarcted areas of human myocardium. J. Immunol. 137: 1945.
41. ENGEL, A. G., and G. BIESECKER. 1982. Complement activation in muscle fiber necrosis: demonstration of the membrane attack complex of complement in necrotic fibers. Ann. Neurol. 12: 289.
42. HILL, J. H., and P. A. WARD. 1971. The phlogistic role of C3 leukotactic fragments in myocardial infarcts of rats. J. exp. Med. 133: 885.
43. MAROKO, P. R., C. B. CARPENTER, M. CHIARIELLO, M. C. FISHBEIN, P. RADVANY, J. D. KNUSTMAN, and S. L. HALE. 1978. Reduction by cobra venom factor of myocardial necrosis after coronary occlusion. J. clin. Invest. 61: 661.
44. TILL, G. O., K. J. JOHNSON, R. KUNKEL, and P. A. Ward. 1982. Intravascular activation of complement and acute lung injury. Dependency on neutrophils and toxic oxygen metabolites. J. clin. Invest. 69: 1126.
45. ROMSON, J. L., B. G. HOOK, S. L. KUNKEL, G. D. ABRAMS, A. SCHORK, and B. R. LUCCHESI. 1983. Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog. Circulation 67: 1016.
46. LITT, M. R., R. W. JEREMY, H. F. WEISMAN, J. A. WINKELSTEIN, and L. C. BECKER. 1989. Neutrophil depletion limited to reperfusion reduces myocardial infarct size after 90 minutes of ischemia. Circulation 80: 1816.
47. KORTHUIS, R. J., M. B. GRISHAM, and D. N. GRANGER. 1988. Leukocyte depletion attenuates vascular injury in postischemic skeletal muscle. Am. J. Physiol. 254: H823.
48. VOGT, W., B. DAMERAU, B. LÜHMANN, D. HESSE, and Y. HALLER. 1986. Complement activation in human lymph: modulation by the contact activation system and by leukocytes. Int. Arch. Allergy appl. Immunol. 79: 423.
49. RUBIN, B. B., A. SMITH, S. LIAUCO, D. ISENMAN, A. D. ROMASCHIN, and P. M. WALKER. 1990. Complement activation and white cell sequestration in postischemic muscle. Am. J. Physiol. 259: H 525.
50. WEISMAN, H. F., T. BARTOW, M. K. LEPPO, H. C. MARSH, G. R. CARSON, M. F. CONCINO, M. P. BOYLE, K. H. ROUX, M. L. WEISFELDT, and D. T. FEARON. 1990. Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing postischemic myocardial inflammation and necrosis. Science 249: 146.
51. SHANDELYA, S. M. L., P. KUPPUSAMY, A. HERSHKOWITZ, M. L. WEISFELDT, and J. L. ZWEIER. 1993. Soluble complement receptor type 1 inhibits the complement pathway and prevents contractile failure in the postischemic heart. Circulation 88: 2812.
52. WARD, P. A., C. G. COCHRANE, and H. J. MÜLLER-EBERHARD. 1966. Further studies on the chemotactic factor of complement and its formation in vivo. Immunology 11: 141.
53. WANG, C., S. BARBASHOV, R. M. JACK, P. F. WELLER, and A. NICHOLSON-WELLER. 1995. Hemolytically inactive C5b67 complex: an agonist of polymorphonuclear leukocytes. Blood 85: 2570.
54. ADLER, S., P. J. BAKER, R. J. JOHNSON, R. F. OCHI, P. PRITZL, and W. G. COUSER. 1986. Complement membrane attack complex stimulates production of reactive oxygen metabolites by cultured rat mesangial cells. J. clin. Invest. 77: 762.